  We develop a variable population age-structured ODE model to investigate the
role of Intermittent Preventive Treatment (IPT) in averting malaria-induced
mortalities in children, as well as its related cost in promoting the spread of
anti-malarial drug resistance. IPT, a malaria control strategy in which a full
curative dose of an antimalarial medication is administered to vulnerable
asymptomatic individuals at specified intervals, has been shown to have a
positive impact on reducing malaria transmission and deaths in children and
pregnant women. However, it can also promote drug resistance spread. Our
mathematical model is used to explore IPT effects on drug resistance in
holoendemic malaria regions while quantifying the benefits in deaths averted.
Our model includes both drug-sensitive and drug-resistant strains of the
parasite as well as interactions between human hosts and mosquitoes. The basic
reproduction numbers for both strains as well as the invasion reproduction
numbers are derived and used to examine the role of IPT on drug resistance.
Numerical simulations show the individual and combined effects of IPT and
treatment of symptomatic infections on the prevalence levels of both parasite
strains and on the number of lives saved. The results suggest that while IPT
can indeed save lives, particularly in the high transmission region, certain
combinations of drugs used for IPT and drugs used to treat symptomatic
infection may result in more deaths when resistant parasite strains are
circulating. Moreover, the half-lives of the treatment and IPT drugs used play
an important role in the extent to which IPT may influence the rate of spread
of the resistant strain. A sensitivity analysis indicates the model outcomes
are most sensitive to the reduction factor of transmission for the resistant
strain, rate of immunity loss, and the clearance rate of sensitive infections.
